At first, I was skeptical, like many of the people I read about in ProNerve6 reviews. However, after reading through multiple ...

Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Diabetic Peripheral Neuropathy.

AKP-11 is under clinical development by Akaal Pharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I drugs for Autoimmune Disorders have a 73% phase transition ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today annou ...

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Young adults face rising cancer rates — and barriers to timely interventions. From now until the end of the year, all ...

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

“We’ve been on a decade-long mission to try to understand why that is,” Schneider said. He led a clinical study of Black ...

According to the results of a new study, “cannabis-based medicines may be effective in treating the pain and symptoms of ...